{"organizations": [], "uuid": "d2a7a704807df34cddacff852046979f2e3a73ca", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180523.html", "section_title": "Archive News &amp; Video for Wednesday, 23 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-three-archs-shares-of-acelrx-stock/brief-three-archs-shares-of-acelrx-stock-acquired-in-transaction-led-by-leerink-revelation-partners-and-industry-ventures-idUSFWN1SU0MC", "country": "US", "domain_rank": 408, "title": "BRIEF-Three Arch's Shares Of AcelRx Stock Acquired In Transaction Led By Leerink Revelation Partners And Industry Ventures", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-23T19:27:00.000+03:00", "replies_count": 0, "uuid": "d2a7a704807df34cddacff852046979f2e3a73ca"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-three-archs-shares-of-acelrx-stock/brief-three-archs-shares-of-acelrx-stock-acquired-in-transaction-led-by-leerink-revelation-partners-and-industry-ventures-idUSFWN1SU0MC", "ord_in_thread": 0, "title": "BRIEF-Three Arch's Shares Of AcelRx Stock Acquired In Transaction Led By Leerink Revelation Partners And Industry Ventures", "locations": [], "entities": {"persons": [{"name": "leerink", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-three arch", "sentiment": "negative"}, {"name": "leerink revelation partners and industry ventures", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "acelrx pharmaceuticals inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 23 (Reuters) - AcelRx Pharmaceuticals Inc:\n* THREE ARCH’S SHARES OF ACELRX COMMON STOCK ACQUIRED IN A PRIVATE TRANSACTION LED BY LEERINK REVELATION PARTNERS AND INDUSTRY VENTURES\n* ACELRX PHARMACEUTICALS INC - NO CHANGES WERE MADE TO COMPOSITION OR SIZE OF ACELRX’S BOARD OF DIRECTORS\n* ACELRX PHARMACEUTICALS - ALL OF CO’S SHARES OWNED BY THREE ARCH ACQUIRED BY INVESTORS LED BY LEERINK REVELATION PARTNERS, INDUSTRY VENTURES\n* ACELRX PHARMACEUTICALS INC - REMAIN ON TRACK TO ACHIEVE REMAINING KEY MILESTONES THIS YEAR\n* ACELRX PHARMACEUTICALS INC - THREE ARCH FUNDS IN DISSOLUTION PROCESS AND ARE EACH FINALIZING LIQUIDATION OF THEIR ENTIRE RESPECTIVE PORTFOLIOS\n* ACELRX PHARMACEUTICALS INC - THREE ARCH FUNDS REMAINING ASSETS COMPRISED OF 9.4 MILLION SHARES IN AGGREGATE ACROSS ALL OF FUNDS Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-23T19:27:00.000+03:00", "crawled": "2018-05-24T20:37:48.009+03:00", "highlightTitle": ""}